Biocon Q4 net profit declines 57% to ₹198.6 crore
after close1 source ↓written by the desknot a recommendation
- in consolidated net
- 56.8% decline
- for Q4 FY26
- ₹198.6 crore
- revenue rose
- ₹4,516.6 crore
- YoY
- ₹4,417 crore
- expenses increased
- ₹4,241.2 crore
Biocon Ltd reported a 56.8% decline in consolidated net profit to ₹198.6 crore for Q4 FY26, impacted by an exceptional item outgo of ₹80.4 crore. Consolidated revenue rose to ₹4,516.6 crore, up from ₹4,417 crore YoY. Total expenses increased to ₹4,241.2 crore from ₹3,987.5 crore in the previous year.
The board has proposed a final dividend of 50 paise per equity share, pending shareholder approval. This significant profit drop may affect investor sentiment in the near term.
Not investment advice. For informational purposes only.